HYDROGEL DRUG DELIVERY IMPLANTS
    2.
    发明申请
    HYDROGEL DRUG DELIVERY IMPLANTS 审中-公开
    HYDROGEL药物递送植入物

    公开(公告)号:US20160166504A1

    公开(公告)日:2016-06-16

    申请号:US14965258

    申请日:2015-12-10

    申请人: Incept, LLC

    IPC分类号: A61K9/00 A61K9/50 A61K39/395

    摘要: Materials and methods for treating a patient, optionally a patient with an eye disease, comprising providing a collection of particles that comprise a first biodegradable material that is a hydrogel or a xerogel and a therapeutic agent, with the first material, before biodegradation, having a rate of release for the therapeutic agent as measured in physiological solution, and forming a second hydrogel ex vivo or in situ on a tissue of the patient at a site of intended use, optionally at or near an eye, that at least partially coats the collection of particles. The agent is released to treat the patient.

    摘要翻译: 用于治疗患者,任选地患有眼睛疾病的患者的材料和方法,包括在生物降解之前提供包含作为第一种材料的水凝胶或干凝胶和治疗剂的第一可生物降解材料的颗粒的集合, 在生理溶液中测量的治疗剂的释放速率,以及在预期用途的部位(任选地在眼睛附近或眼睛附近)离体或原位形成患者组织上的第二水凝胶,其至少部分地涂覆所述收集 的颗粒。 该药物被释放以治疗患者。